These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29055786)

  • 1. Carbon monoxide releasing molecule improves structural and functional cardiac recovery after myocardial injury.
    Segersvärd H; Lakkisto P; Hänninen M; Forsten H; Siren J; Immonen K; Kosonen R; Sarparanta M; Laine M; Tikkanen I
    Eur J Pharmacol; 2018 Jan; 818():57-66. PubMed ID: 29055786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Protective effect of carbon monoxide releasing molecules 2 on post-resuscitation myocardial dysfunction in rats].
    Liu M; Wang F; Liu F; Du F; Wang XH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Apr; 47(4):311-317. PubMed ID: 31060191
    [No Abstract]   [Full Text] [Related]  

  • 3. Carbon monoxide releasing molecule-3 improves myocardial function in mice with sepsis by inhibiting NLRP3 inflammasome activation in cardiac fibroblasts.
    Zhang W; Tao A; Lan T; Cepinskas G; Kao R; Martin CM; Rui T
    Basic Res Cardiol; 2017 Mar; 112(2):16. PubMed ID: 28168403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of carbon monoxide release molecule-2 on sepsis-induced myocardial dysfunction in rats].
    Zhang S; Qi W; Wang F; Xu Y; Wang X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Sep; 31(9):1097-1101. PubMed ID: 31657332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heme oxygenase-1 and carbon monoxide promote neovascularization after myocardial infarction by modulating the expression of HIF-1alpha, SDF-1alpha and VEGF-B.
    Lakkisto P; Kytö V; Forsten H; Siren JM; Segersvärd H; Voipio-Pulkki LM; Laine M; Pulkki K; Tikkanen I
    Eur J Pharmacol; 2010 Jun; 635(1-3):156-64. PubMed ID: 20303947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbon monoxide releasing molecule‑2 attenuated ischemia/reperfusion‑induced apoptosis in cardiomyocytes via a mitochondrial pathway.
    Zhao S; Lin Q; Li H; He Y; Fang X; Chen F; Chen C; Huang Z
    Mol Med Rep; 2014 Feb; 9(2):754-62. PubMed ID: 24337106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved myocardial function after cold storage with preservation solution supplemented with a carbon monoxide-releasing molecule (CORM-3).
    Musameh MD; Green CJ; Mann BE; Fuller BJ; Motterlini R
    J Heart Lung Transplant; 2007 Nov; 26(11):1192-8. PubMed ID: 18022087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myocardial infarction in streptozotocin-induced hyperglycaemic rats: protection by a carbon monoxide-releasing molecule (CORM-3).
    Filippo CD; Perretti M; Rossi F; Ferraraccio F; Motterlini R; D'Amico M
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Feb; 385(2):137-44. PubMed ID: 22038495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of carbon monoxide releasing molecule-liberated CO on severe acute pancreatitis in rats.
    Chen P; Sun B; Chen H; Wang G; Pan S; Kong R; Bai X; Wang S
    Cytokine; 2010 Jan; 49(1):15-23. PubMed ID: 19900821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CORM-2 inhibits intracerebral hemorrhage-mediated inflammation.
    Chen Z; Zhang H; Zhou J; Stone C; Ding Y; Zhang Y; Ren C; Yin X; Meng R
    Neurol Res; 2021 Oct; 43(10):846-853. PubMed ID: 34107862
    [No Abstract]   [Full Text] [Related]  

  • 11. The CO-releasing molecule CORM-3 protects adult cardiomyocytes against hypoxia-reoxygenation by modulating pH restoration.
    Portal L; Morin D; Motterlini R; Ghaleh B; Pons S
    Eur J Pharmacol; 2019 Nov; 862():172636. PubMed ID: 31491405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of angiotensin II blockade on cardiomyocyte regeneration after myocardial infarction in rats.
    Segersvärd H; Lakkisto P; Forsten H; Immonen K; Kosonen R; Palojoki E; Kankuri E; Harjula A; Laine M; Tikkanen I
    J Renin Angiotensin Aldosterone Syst; 2015 Mar; 16(1):92-102. PubMed ID: 23629679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of exogenous carbon monoxide-releasing molecule 2 intervention in vitro on formation of human neutrophil extracellular traps stimulated by endotoxin/lipopolysaccharide and its mechanism].
    Song M; Wang X; Qin W; Zhuang M; Xu X; Zhang Y; Sun B
    Zhonghua Shao Shang Za Zhi; 2016 Feb; 32(2):82-8. PubMed ID: 26902274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell damage following carbon monoxide releasing molecule exposure: implications for therapeutic applications.
    Winburn IC; Gunatunga K; McKernan RD; Walker RJ; Sammut IA; Harrison JC
    Basic Clin Pharmacol Toxicol; 2012 Jul; 111(1):31-41. PubMed ID: 22269084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbon Monoxide Releasing Molecule A1 Reduces Myocardial Damage After Acute Myocardial Infarction in a Porcine Model.
    Iqbal J; Chamberlain J; Alfaidi M; Hughes M; Alizadeh T; Casbolt H; Evans P; Mann B; Motterlini R; Francis S; Gunn J
    J Cardiovasc Pharmacol; 2021 Nov; 78(5):e656-e661. PubMed ID: 34328710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule.
    Clark JE; Naughton P; Shurey S; Green CJ; Johnson TR; Mann BE; Foresti R; Motterlini R
    Circ Res; 2003 Jul; 93(2):e2-8. PubMed ID: 12842916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of HO-1 by carbon monoxide releasing molecule-2 attenuates thrombin-induced COX-2 expression and hypertrophy in primary human cardiomyocytes.
    Chien PT; Lin CC; Hsiao LD; Yang CM
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):349-59. PubMed ID: 26385185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbon monoxide protects against ischemia-reperfusion injury in an experimental model of controlled nonheartbeating donor kidney.
    Bagul A; Hosgood SA; Kaushik M; Nicholson ML
    Transplantation; 2008 Feb; 85(4):576-81. PubMed ID: 18347537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of exogenous carbon monoxide-releasing molecules 2 on endotoxin/lipopolysaccharide-induced abnormal activation of platelets of healthy human donors].
    Liu D; Zhuang M; Zhang J; Chen J; Sun B
    Zhonghua Shao Shang Za Zhi; 2015 Oct; 31(5):354-60. PubMed ID: 26714404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The severity of microvascular dysfunction due to compartment syndrome is diminished by the systemic application of CO-releasing molecule-3.
    Lawendy AR; Bihari A; Sanders DW; Potter RF; Cepinskas G
    J Orthop Trauma; 2014 Nov; 28(11):e263-8. PubMed ID: 24675751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.